Stephanie L Goff

27PUBLICATIONS
103CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 06, 2026
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical response.

|Apr 29, 2026
Vaccination rescues dysfunctional T cell therapy by amplifying rare stem-like antitumor CD8+ T cells.

|Dec 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers.

S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst

|Dec 17, 2025
Selective expansion of T-cell receptor engineered T cells with increased stem-like phenotypes using neoantigen stimulation.

Sanghyun P Kim, Noam Levin, Youngseo Jo

|Nov 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

George Coukos, Marco Donia, Brian R Gastman

|Oct 15, 2025
Facts and Hopes for Neoantigen-Enriched TIL.

Siqi C Brough, Kristen L Skonieczny, Stav Leibou

Pageof 5

Frequent Collaborators

15 joint publications

Paul Robbins

12 joint publications

James Yang

10 joint publications

Jared J Gartner

10 joint publications

Steven A Rosenberg